Zydus Cadila gets nod to sale stake in WHPL

16 Apr 2020 Evaluate

Zydus Cadila’s board of directors has approved and signed the Definitive Agreement for sale of 9,44,233 equity shares of Rs 10 each fully paid-up, representing 2% of the total paid-up share capital of Windlas Healthcare (WHPL), a subsidiary company to Windlas Biotech (WBPL).

Upon completion of the transaction in relation to the sale of the said equity shares, the total shareholding of the Company in WHPL will reduce to 49.00% from 51.00% and WHPL will cease to be the subsidiary of the company.

Cadila Healthcare is an India-based pharmaceutical company. The company's subsidiaries include Zydus Wellness, Liva Pharmaceuticals, Biochem Pharmaceutical Industries, Zydus Technologies, German Remedies, Dialforhealth India, Dialforhealth Unity and Dialforhealth Greencross, among others.

 

Zydus Lifesciences Share Price

890.20 -6.40 (-0.71%)
29-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.30
Dr. Reddys Lab 1208.45
Cipla 1320.35
Zydus Lifesciences 890.20
Lupin 2131.80
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×